Advertisement
JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Shistik, E.
Right arrow Articles by Ivanina, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Shistik, E.
Right arrow Articles by Ivanina, T.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

J Biol Chem, Vol. 274, Issue 44, 31145-31149, October 29, 1999


The N terminus of the Cardiac L-type Ca2+ Channel alpha 1C Subunit
THE INITIAL SEGMENT IS UBIQUITOUS AND CRUCIAL FOR PROTEIN KINASE C MODULATION, BUT IS NOT DIRECTLY PHOSPHORYLATED*

Elena ShistikDagger , Tal Keren-RaifmanDagger , Gregory H. Idelson§, Yakov Blumenstein, Nathan Dascal, and Tatiana Ivanina

From the Department of Physiology and Pharmacology, Sackler School of Medicine, Tel Aviv University, Ramat Aviv 69978, Israel and the § Alomone Labs Ltd., P. O. Box 4287, Jerusalem 91042, Israel

    ABSTRACT
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS AND DISCUSSION
REFERENCES

The first 46 amino acids (aa) of the N terminus of the rabbit heart (RH) L-type cardiac Ca2+ channel alpha 1C subunit are crucial for the stimulating action of protein kinase C (PKC) and also hinder channel gating (Shistik, E., Ivanina, T., Blumenstein, Y., and Dascal, N. (1998) J. Biol. Chem. 273, 17901-17909). The mechanism of PKC action and the location of the PKC target site are not known. Moreover, uncertainties in the genomic sequence of the N-terminal region of alpha 1C leave open the question of the presence of RH-type N terminus in L-type channels in mammalian tissues. Here, we demonstrate the presence of alpha 1C protein containing an RH-type initial N-terminal segment in rat heart and brain by using a newly prepared polyclonal antibody. Using deletion mutants of alpha 1C expressed in Xenopus oocytes, we further narrowed down the part of the N terminus crucial for both inhibitory gating and for PKC effect to the first 20 amino acid residues, and we identify the first 5 aa as an important determinant of PKC action and of N-terminal effect on gating. The absence of serines and threonines in the first 5 aa and the absence of phosphorylation by PKC of a glutathione S-transferase-fusion protein containing the initial segment suggest that the effect of PKC does not arise through a direct phosphorylation of this segment. We propose that PKC acts by attenuating the inhibitory action of the N terminus via phosphorylation of a remote site, in the channel or in an auxiliary protein, that interacts with the initial segment of the N terminus.

    INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS AND DISCUSSION
REFERENCES

Voltage-dependent L-type Ca2+ channels regulate contraction of cardiac and smooth muscle and excitability and gene expression in the brain (2-4). They consist of three subunits: alpha 1 (main, pore-forming subunit), beta , and alpha 2/delta . The alpha 1 subunits in the heart, smooth muscle, and brain are products of the alpha 1C gene (5). The existence of several cDNA isoforms and the genomic sequence of the alpha 1C DNA suggest the presence of splice variants of RNA and thus of several isoforms of the alpha 1C protein (6-8), but the actual composition of alpha 1C protein isoforms in tissues is still poorly characterized.

The alpha 1C subunit appears to be the main target for modulation by protein kinases A and C (PKA and PKC,1 respectively), although beta  is also a substrate (9). Both kinases increase the activity of the channel (10-12). PKC has been proposed to mediate the enhancement of L-type Ca2+ channels by intracellular ATP (13), angiotensin II (14), glucocorticoids (15), PACAP (16), and arginine-vasopressin (17). After the initial enhancement by PKC-activating phorbol esters, the Ca2+ current is often decreased (18, 19), but it is not clear whether the inhibition is phosphorylation-related (20, 21). The dual effect of PKC activators is fully reconstituted in Xenopus oocytes expressing alpha 1C, with or without alpha 2/delta and/or beta ; the presence of beta  attenuates the enhancing action of PKC (21, 22). In the nerve cells, either stimulation (23-26) or inhibition (27-29) of L-type channels by PKC has been reported.

The alpha 1 subunit is composed of four homologous membrane-spanning internal domains, each with six transmembrane alpha -helixes and a pore-forming reentrant P loop (30). C and N termini and linkers between domains I-II, II-III, and III-IV are cytosolic. The initial 46 aa of the N terminus of rabbit heart (RH) alpha 1C are crucial for PKC modulation (1). The cytosolic N-terminal part of RH alpha 1C is 154 aa long. Deletion of the first 40 aa or more causes a 5-10-fold increase in the current via RH-type Ca2+ channels expressed in Xenopus oocytes (1, 31). This is a result of a change in channel gating because the truncation causes an increase in open probability, without increasing the amount of alpha 1C protein in the plasma membrane (1). These and additional findings led us to propose that the N terminus of alpha 1C acts as an inhibitory gate, and its removal enhances channel activation; PKC increases the current by attenuating the inhibitory action of the N terminus (1). It is not known whether PKC phosphorylates the N terminus.

Despite the importance of the first 46 aa of the RH-type N terminus, its presence in L-type channel proteins in vivo remains uncertain. The only other cDNA of alpha 1C containing a stretch encoding this protein sequence is that cloned from rat aorta and heart (6). alpha 1C cDNAs cloned from rabbit lung, human heart, and rat brain (7, 32-34) do not encode this stretch (see Fig. 2A). It has been proposed that these variations correspond to splice variants of the alpha 1C gene (7), but even this is not certain. The structure of the genomic DNA of human alpha 1C has not been fully resolved in this region; none of the known exons correspond to the RH-type N terminus (8). In contrast, a recent study that utilized an RNase protection assay showed that RNA of the RH-type initial segment is predominant in human heart (35). These discrepancies make it important to clarify whether L-type Ca2+ channel isoforms with the RH-type N terminus are common in mammalian tissues.

Here we demonstrate the abundance of the RH-type N terminus in rat heart and brain and map the segment critical for PKC modulation and for inhibition of gating to the very beginning of the N terminus. Our results strongly suggest that PKC effect is not mediated by phosphorylation of this initial segment.

    EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS AND DISCUSSION
REFERENCES

cDNA Constructs and mRNA-- cDNAs and RNAs of RH alpha 1C and alpha 2/delta were as described (1). To create alpha 1C N-terminal truncations, PCR amplification with Vent polymerase (New England Biolabs) was performed for alpha 1CDelta N2-5, alpha 1CDelta N2-20, and alpha 1CDelta N2-25, as described for alpha 1CDelta N2-46 and alpha 1CDelta N2-139 (1), introducing a SalI site followed by an initiation codon (ATG) and then by the original wild-type (WT) alpha 1C sequence starting from the desired base (amino acid numbers correspond to the RH alpha 1C sequence (36)).

The cDNA constructs of the GST fusion proteins of the whole N terminus (N1-154) and of the loop I-II were described previously (1). The cDNAs for N47-154 and N87-154 (encoding the corresponding alpha 1C segments) were made by a PCR procedure and inserted into EcoRI and NotI sites of pGEX-4T-1 (Amersham Pharmacia Biotech) and thus linked in-frame to GST. N1-46(S44A), with serine 44 replaced by alanine, and a cDNA for N(neuronal)1-124, encoding aa 1-124 of rat brain rbCII alpha 1C isoform (7), were inserted into EcoRI and XhoI sites of pGEX-4T-1. All PCR products were sequenced at the Tel Aviv University Sequencing Facility. Fusion proteins were generated by transformation into Escherichia coli strain BL-21 (Stratagene) followed by induction with 1 mM isopropyl-1-thio-b-D-galactopyranoside and affinity purification with GST beads (Amersham Pharmacia Biotech) and elution with 15 or 20 mM reduced glutathione. In the preparation of N1-46(S44A), protease inhibitors were used: aprotinin (10 µg/ml), benzamidine (5 mM), Pefabloc SC (0.2 mM), and EDTA (1 mM). N1-46(S44A) was additionally dialyzed to 0.1 M ammonium acetate buffer, pH 7.0, aliquoted, and lyophilized. Materials and enzymes for molecular biology were purchased from Roche Molecular Biochemicals, Promega, or MBI Fermentas.

Oocytes and Electrophysiology-- Xenopus laevis frogs were maintained and dissected as described (37). Oocytes were injected with equal amounts (by weight) of the mRNAs of alpha 1C or its mutants, of alpha 2/delta , and, in the experiment shown in Fig. 2F, of beta 2A (2.5 ng for electrophysiological, 5 ng for biochemical experiments) and incubated for 3-5 days at 20-22 °C in NDE96 solution (96 mM NaCl, 2 mM KCl, 1 mM MgCl2, 1 mM CaCl2, 2.5 mM Na-pyruvate, 50 µg/ml gentamycin, 5 mM HEPES, pH 7.5). Whole cell currents were recorded using the Gene Clamp 500 amplifier (Axon Instruments, Foster City, CA) using the two-electrode voltage clamp technique in a solution containing 40 mM Ba(OH)2, 50 mM NaOH, 2 mM KOH, and 5 mM HEPES, titrated to pH 7.5 with methanesulfonic acid (37). Stimulation, data acquisition, and analysis were performed using pCLAMP software (Axon Instruments). Ba2+ currents were measured by a 200-ms step to 20 mV from a holding potential of -80 mV. To study the effect of PMA (10 nM; Sigma), the voltage pulses were delivered every 10-20 s (see Ref. 1 for details of PMA use).

Antibodies-- Card-I and Card-C antibodies were kindly provided by M. M. Hosey (Northwestern University, Chicago, IL) (38). A new antibody (Card-N) was raised against the GST fusion protein N1-46(S44A). Two New Zealand female rabbits were immunized with 0.3 mg of N1-46(S44A) in complete Freund's adjuvant, and reimmunized monthly with 0.2 mg of N1-46(S44A) in incomplete Freund's adjuvant. Blood samples were taken 10 days after the immunization. The specific antibodies in the sera were detected by enzyme-linked immunosorbent assay on immobilized N1-46(S44A), in the presence of excess of soluble GST (20 µg/ml). The reacting sera were chosen for antibody purification. Immobilized N1-46S44A, GST, and E. coli lysate were prepared using Affi-Gel 10 (Bio-Rad) according to the recommendations of the manufacturer. Crude IgG fraction was prepared from the serum by 50% saturation (NH4)2SO4 precipitation and dialyzed in 100 mM Tris-HCl, pH 8.0. To eliminate anti-GST antibodies, the IgG fraction was incubated with GST beads (Affi-Gel 10, Bio-Rad) overnight at 4 °C. The bound material was eluted with 4.5 M MgCl2. The procedure was repeated with the unbound material several times until no antibodies were eluted from GST beads. To eliminate antibodies against possible contaminating bacterial proteins, the same procedure was performed with immobilized heat-shocked E. coli lysate proteins. The unbound material was applied to N1-46S44A-GST beads (Affi-Gel 10, Bio-Rad), incubated 2 h at room temperature or overnight at 4 °C, and eluted with 3.5 M MgCl2. The eluted antibodies were dialyzed against 10 mM Tris-HCl, pH 8.0, and then against phosphate-buffered saline containing 0.025% NaN3.

Immunochemistry of the Expressed alpha 1C in Xenopus Oocytes-- Immunochemistry was performed as described (37). Oocytes were injected with mRNAs and incubated in NDE solution containing 0.5 mCi/ml [35S]methionine/cysteine (Amersham Pharmacia Biotech) for 3-4 days at 22 °C. 5 oocytes were homogenized, and proteins were solubilized, immunoprecipitated, and electrophoresed on 6% polyacrylamide-SDS gel.

Preparation of Tissues and Western Blot Analysis-- Tissues from 3-week old Wistar rats were frozen in liquid N2, crushed while frozen, and homogenized on ice in a buffer (0.32 M sucrose, 1 mM EDTA, 50 mM Tris) containing the Roche Molecular Biochemicals protease inhibitor mixture. Crude membranes were prepared by centrifugations at 4 °C (two times at 1100 × g for 10 min to remove the debris and the nuclei, and then for 1 h at 100,000 × g) and resuspension of the pellet in the above buffer. The amount of protein was determined by the Bradford assay. The membranes were stored in aliquots at -80 °C. Protein samples (35 µg per lane) were separated on 6% polyacrylamide-SDS gels and transferred to nitrocellulose membranes for Western blotting with the various antisera at the following dilutions: Card-C, 1:1000; Card-I, 1:375; Card-N, 1:750 or 1:1000. The filters were visualized using the SuperSignal Substrate kit (Pierce).

Phosphorylation of GST-Fusion Proteins by PKC-- The procedure was as described by Kozasa and Gilman (39). 8 µg of each GST-fusion protein were incubated for 20 min at 30 °C with 1 µl of alpha -, beta -, gamma -PKC mixture (Roche Molecular Biochemicals) in 100 µl of 25 mM Tris-HCl (pH 7.5), 5 mM MgCl2, 125 µM CaCl2, 1 mM dithiothreitol, 10 µM [gamma -32P]ATP (5000 cpm/pmol), 10 µg/ml phosphatidylserine-diolein (Sigma), 0.05% CHAPS. The products were precipitated in 3 volumes of ethanol at -20° for 1 h. 32P-radiolabeled fusion proteins were separated on an 8% acrylamide Laemmli gel containing 0.1% SDS, dried, and exposed to x-ray film.

    RESULTS AND DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS AND DISCUSSION
REFERENCES

The RH-type N Terminus Is Present in Rat Heart and Brain-- A polyclonal antibody (Card-N) directed against a GST fusion protein of the first 46 aa of the RH-type alpha 1C N terminus was raised in rabbit (since a GST-fusion construct containing the WT 46 aa of RH alpha 1C appeared to degrade in the course of bacterial synthesis, Card-N was actually raised against a more stable fusion protein, N1-46(S44A), in which serine 44 was mutated to alanine). Card-N was compared with two previously characterized antibodies, Card-I (against residues 812-929 of the II-III domain linker) and Card-C (against residues 2156-2169 in the end of the C terminus) (37, 38). Card-N immunoprecipitated the WT RH alpha 1C protein expressed in Xenopus oocytes and metabolically labeled with [35S]methionine/cysteine (Fig. 1A, lane 2), but not the truncated mutant missing the first 46 aa, alpha 1CDelta N2-46 (Fig. 1A, lane 1). Card-I and Card-C immunoprecipitated both the WT alpha 1C and alpha 1CDelta N2-46 (Fig. 1, A and B); the level of expression of the full-length alpha 1C was higher than that of alpha 1CDelta N2-46 (Fig. 1B), as reported previously (1). Card-C precipitated the WT channel more efficiently than Card-N (Fig. 1A). No 35S-labeled alpha 1C was detected in oocytes that were not injected with RNA by any of the antibodies (Fig. 1, A and B). The fact that bands of the same size of WT alpha 1C are detected by antibodies directed to the extreme N and C termini and a mid-portion of the channel supports the notion (37) that the oocyte expresses the whole-length protein not truncated at any of its termini. Notably, under the conditions used here, the WT alpha 1C protein runs on SDS-polyacrylamide gels as an ~207-kDa band, as reported previously in the oocytes (1, 37). Because the calculated molecular mass of this protein is ~242 kDa (36), the error (underestimate) of its size is about 35 kDa. The underestimation may result from the established fact that hydrophobic proteins tend to run on SDS-polyacrylamide gels faster than standard, water-soluble molecular mass markers (40).


View larger version (30K):
[in this window]
[in a new window]
 
Fig. 1.   Detecting the Ca2+ channel alpha 1C subunit isoforms in Xenopus oocytes and in tissues with Card-N, Card-I, and Card-C antibodies. A, Card-N and Card-C immunoprecipitate [35S]methionine/cysteine-labeled alpha 1C from oocytes expressing the WT alpha 1C (lanes 2 and 4) but not from uninjected oocytes of the same donor (lanes 3 and 5). Card-N fails to immunoprecipitate alpha 1CDelta N2-46 (lane 1). B, Card-C and Card-I immunoprecipitate alpha 1CWT (lanes 2 and 5) and alpha 1CDelta N2-46 (lanes 3 and 6) from oocytes of one donor injected with the corresponding RNAs, but not from uninjected oocytes (lanes 1 and 4). In panels A and B, alpha 1C was coexpressed with alpha 2/delta . In each lane, immunoprecipitates from 5 oocytes were loaded. C, Western blot of rat ventricular membranes with the Card-N antibody in the absence (lane 2) or presence (lane 1) of the GST-fusion protein N1-46(S44A). 10 ml of the antibody (dilution 1:1000) were incubated overnight at 4 °C with 80 µg of N1-46(S44A), then additional 80 µg were added, and the antibody/GST fusion protein mixture (lane 1), or 10 ml of the antibody without N1-46(S44A) (lane 2), were incubated with the nitrocellulose membranes for 2 h at room temperature. D, detecting the Ca2+ channel alpha 1C subunit isoforms in ventricle, brain, and liver by immunoblots with Card-N, Card-I, and Card-C.

Western blots of rat ventricle membranes with Card-N revealed a major band at ~207 kDa and a minor band at ~160 kDa; labeling of both bands was completely suppressed in the presence of the N1-46(S44A) GST-fusion protein against which the antibody was raised (Fig. 1C). This result confirms the specificity of Card-N and demonstrates, for the first time on the protein level, the presence of an RH-type initial segment in the N terminus of alpha 1C in the rat heart.

Western blots of rat heart (ventricle), brain, and liver were done with all three antibodies (Fig. 1D). Card-C antibody detected an ~207-kDa band in the ventricle. A higher, ~240-kDa band was observed in all tissues. However, we cannot discard the possibility that this labeling is nonspecific because this band was not detected by the other two antibodies. The Card-I and Card-N antibodies detected the ~207-kDa band in ventricle and in the brain, although labeling with Card-I was weak. This may be because of sequence divergence between the rabbit cardiac alpha 1C and isoforms of rat brain channel that show variability in the loop II-III (41). With Card-N, the intensity of this band varied in different blots, and in some instances it was even stronger in the brain than in the ventricle (data not shown). Because brain alpha 1C was not detected by Card-C but detected by Card-N, the very end of the C terminus in a majority of brain alpha 1C protein may be missing or different from the cardiac one. An additional band at ~160 kDa was detected in the liver by Card-I and Card-N but not by Card-C; Card-N detected a similar band in the ventricle. These results support the notion (42) that only a small percentage of the L-type channel in the heart is truncated at the end of its C terminus (see also Ref. 43). The actual size of the truncated protein is probably higher than 160 kDa because of the underestimation of the size by SDS-polyacrylamide gel electrophoresis in our conditions. Because alpha 1C RNA has been found in whole liver but not in hepatocytes (44), the ~160-kDa protein may be present in nonhepatocyte tissues, e.g. in the blood vessels.

The main conclusion of this part of the study is that alpha 1C protein containing the RH-type N terminus is present in rat heart and brain, and the L-type Ca2+ current in these tissues can be expected to be stimulated by PKC. The variability of PKC effects on neuronal L-type channels (23-29) may result from the presence of different isoforms of alpha 1C in different neuronal cell types.

The First Five Amino Acid Residues of alpha 1C Are Critical for PKC Modulation-- Deletion of the first 46 aa residues of the alpha 1C, which are unique to the RH-type N terminus (Fig. 2A), increases the Ca2+ channel current and also eliminates the PKC-induced augmentation (1). The effects of deletions shorter than 40 aa have not been studied (1, 45). To narrow down the segment crucial for PKC effect, we have prepared three additional deletion mutants: alpha 1CDelta N2-5, alpha 1CDelta N2-20, and alpha 1CDelta N2-25, lacking aa 2-5, 2-20, and 2-25, accordingly. All truncated channels produced whole-cell currents 3-10-fold larger than WT in >5 oocyte batches. For a quantitative comparison, RNAs of WT and of four deletion mutants were prepared on the same day, in parallel, and injected (together with alpha 2/delta subunit) into oocytes of the same donor. Fig. 2B shows that deletion of the first 20 aa was sufficient to cause a maximal current increase, similar to that produced by the deletion of 46 or 139 aa. Deletion of aa 2-5 also significantly (p < 0.01) increased the current but less well than of 20 or more aa. Because coexpression of the beta 2A subunit increased WT currents better than those of N-terminal truncation mutants alpha 1CDelta N2-46 and alpha 1CDelta N2-139, we proposed that part of beta 2A-induced enhancement is because of an allosteric hindrance of the N-terminal inhibition of gating (1). Fig. 2F shows that the enhancement of peak currents of alpha 1CDelta N2-5 and alpha 1CDelta N2-20 caused by coexpression of beta 2A is also weaker than that of the WT channels; this was observed at all voltages. Thus, the first 20 aa are crucial for the inhibitory effect of the N terminus on L-type channel gating and on its interaction with beta 2A, and the first 5 aa constitute an important component.


View larger version (41K):
[in this window]
[in a new window]
 
Fig. 2.   The importance of the initial N-terminal segment of alpha 1C in modulation of the channel activity and in mediation of the PKC effect. A, alignment of protein sequences predicted from cDNA clones from rabbit heart (36), rat heart (6), and rat brain rbC-II (7). Identical amino acids are shown by dashes; empty spaces are gaps introduced for optimal sequence alignment. B, comparison of Ca2+ channel currents (carried by Ba2+, IBa) in groups of oocytes of one donor injected with RNAs of the indicated constructs of alpha 1C, together with the RNA of alpha 2/delta . 8 to 9 oocytes were tested in each group. Currents were normalized to the mean IBa measured in the WT group. The increase in IBa compared with control was significant in all groups (p < 0.05 or better, ANOVA multiple comparison test followed by Dunn's test). C, representative current traces in oocytes of one batch expressing alpha 1CWT or alpha 1CDelta N2-5 (with alpha 2/delta ) before and 10 min after the addition of 10 nM PMA. D, time course of PMA effect on IBa in representative oocytes of the same donor, expressing alpha 2/delta and the indicated construct of alpha 1C. In each cell, the stability of the current was verified for at least 3 min before the addition of PMA (not shown). PMA addition is shown as t = 0. E, a summary of the effect of PMA on channels containing alpha 2/delta and either alpha 1CWT, alpha 1CDelta N2-5, or alpha 1CDelta N2-20. Two batches of oocytes, 11 to 12 oocytes in each group. The effect of PMA is presented as percent increase of IBa in each cell 10 min after the addition of PMA. Asterisks indicate statistically significant differences (p < 0.02 or better). F, the effect of coexpression of beta 2A subunit on channels containing alpha 2/delta and either alpha 1CWT, alpha 1CDelta N2-5, or alpha 1CDelta N2-20 (at +10 mV).

Fig. 2 shows representative current traces (Fig. 2C) and time course of the effect of the phorbol ester PMA (Fig. 2D) in oocytes expressing WT, Delta N2-5, or Delta N2-20 alpha 1C (with the alpha 2/delta subunit). Two oocyte batches in which the WT channel showed high sensitivity to PMA, and the Ca2+ channel current was increased 1.6-4-fold (summarized in Fig. 2E), have been used in these experiments. The removal of aa 2-5 reduced the PMA effect by more than 90%; the remaining increase (13 ± 4.4%; mean ± S.E.) was small but statistically significant (p < 0.02). Channels lacking the first 20 aa were insensitive to PMA (6.4 ± 8.1%). Thus, the first 5 aa are very important, and the first 20 aa are crucial for the PKC effect.

PKC Does Not Phosphorylate the Segment Crucial for Its Physiological Effect-- Based on effects of PKC activators and inhibitors, the effect of PMA is expected to result from a PKC-catalyzed phosphorylation (21, 22). Because none of the first 5 aa of alpha 1C are serines or threonines (Fig. 2A), it is not possible that PKC directly phosphorylates this segment. None of the residues in the first 20 aa is a consensus PKC site, but a cryptic site (T10 or S18) might be a target for PKC. Therefore, we have examined in vitro phosphorylation by purified PKC of GST-fusion proteins of segments of the N terminus: N1-46(S44A), N1-154 (the whole N terminus), N47-154, and N84-154. As controls, we used GST and the GST fusion proteins of the loop I-II of RH alpha 1C and of the N terminus of the rat brain alpha 1C, N(neuronal)1-124. Fig. 3 shows that N1-154 and N47-154 were strongly phosphorylated; weaker signals were observed in N87-154 and in N(neuronal)1-124. GST alone, N1-46(S44A), and loop I-II were not phosphorylated. Thus, the first 20 aa, contained within the GST fusion protein N1-46(S44A), are not phosphorylated under these conditions, whereas other parts of the N terminus are. The physiological significance of the phosphorylation of these distal parts of the N terminus is unclear at present.


View larger version (34K):
[in this window]
[in a new window]
 
Fig. 3.   In vitro phosphorylation of alpha 1C fusion proteins by purified PKC. GST-fusion proteins of the indicated constructs were phosphorylated as described under "Experimental Procedures." The products were resolved by SDS-polyacrylamide gel electrophoresis, followed by autoradiography.

In summary, our results demonstrate the presence of alpha 1C protein isoform(s) containing an RH-type N terminus in rat heart (ventricle) and brain. Further, we have demonstrated that the initial 20 amino acids are crucial both for the inhibitory gating by the N terminus, the allosteric interaction of the N terminus with the beta  subunit, and for the PKC effect. Removal of the first 5 aa already strongly hampers the inhibitory function of the N terminus and almost fully abolishes the PKC effect. The correlation between the location of residues crucial for these two functions supports the hypothesis (1) that PKC exerts its stimulating action by attenuating the inhibition imposed on the channel by the N terminus.

Determination of the mechanism of PKC action is a challenge for the future. Our data suggest that the effect of PKC is not attained by a direct phosphorylation of the initial 20 aa of the N terminus. This conclusion is supported both by the amino acid composition of this segment, especially of the first 5 aa crucial for PKC action, and by the absence of phosphorylation of the GST fusion protein containing the initial segment. What can be the mechanism of PKC action? There are at least two possibilities. PKC may phosphorylate a site at alpha 1C which is remote from the initial N-terminal segment but interacts with it directly or allosterically. If such interaction is permissive for N-terminal effect on gating (inhibition), phosphorylation by PKC may weaken the inhibition. Another possibility is that PKC phosphorylates an auxiliary protein, yet unidentified, which either aids the N-terminal inhibition (and the phosphorylation obstructs this effect), or attenuates the N-terminal inhibition when phosphorylated by PKC.

    ACKNOWLEDGEMENTS

We thank Ilana Lotan and Dafna Singer-Lahat for many helpful discussions and for the critical reading of the manuscript, M. Hosey for the gift of Card-C and Card-I antibodies, and T. P. Snutch for the rbCII cDNA.

    FOOTNOTES

* This work was supported by a grant from the Israel Academy of Sciences.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

Dagger These authors contributed equally to this work.

To whom correspondence should be addressed. Tel.: (+972) 3 640 9853; Fax: (+972) 3 640 9113; E-mail: dascaln@post. tau.ac.il.

    ABBREVIATIONS

The abbreviations used are: PKC, protein kinase C; aa, amino acid; GST, glutathione S-transferase; PCR, polymerase chain reaction; PKA, protein kinase A; PMA, 4-beta -phorbol 12-myristate 13-acetate; RH, rabbit heart; WT, wild-type; CHAPS, 3-[(3-cholamidopropyl)dimethylammonio]-1-propanesulfonic acid.

    REFERENCES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS AND DISCUSSION
REFERENCES

1. Shistik, E., Ivanina, T., Blumenstein, Y., and Dascal, N. (1998) J. Biol. Chem. 273, 17901-17909[Abstract/Free Full Text]
2. Snutch, T. P., and Reiner, P. B. (1992) Curr. Opin. Neurobiol. 2, 247-253[CrossRef][Medline] [Order article via Infotrieve]
3. Reuter, H. (1983) Nature 301, 569-574[CrossRef][Medline] [Order article via Infotrieve]
4. Finkbeiner, S., and Greenberg, M. E. (1998) J. Neurobiol. 37, 171-189[CrossRef][Medline] [Order article via Infotrieve]
5. De Waard, M., Gurnett, C. A., and Campbell, K. P. (1996) Ion Channels 4, 41-87[Medline] [Order article via Infotrieve]
6. Koch, W. J., Ellinor, P. T., and Schwartz, A. (1990) J. Biol. Chem. 265, 17786-17791[Abstract/Free Full Text]
7. Snutch, T. P., Tomlinson, W. J., Leonard, J. P., and Gilbert, M. M. (1991) Neuron 7, 45-57[CrossRef][Medline] [Order article via Infotrieve]
8. Soldatov, N. M. (1994) Genomics 22, 77-87[CrossRef][Medline] [Order article via Infotrieve]
9. Puri, T. S., Gerhardstein, B. L., Zhao, X. L., Ladner, M. B., and Hosey, M. M. (1997) Biochemistry 36, 9605-9615[CrossRef][Medline] [Order article via Infotrieve]
10. Trautwein, W., and Hescheler, J. (1990) Annu. Rev. Physiol. 52, 257-274[CrossRef][Medline] [Order article via Infotrieve]
11. Tsien, R. W. (1983) Annu. Rev. Physiol. 45, 341-358[CrossRef][Medline] [Order article via Infotrieve]
12. Wickman, K., and Clapham, D. E. (1995) Physiol. Rev. 75, 865-885[Abstract/Free Full Text]
13. McHugh, D., and Beech, D. J. (1997) J. Physiol. Lond. 500, 311-317[Abstract/Free Full Text]
14. Dosemeci, A., Dhallan, R. S., Cohen, N. M., Lederer, W. J., and Rogers, T. B. (1988) Circ. Res. 62, 347-357[Abstract/Free Full Text]
15. Kato, H., Hayashi, T., Koshino, Y., Kutsumi, Y., Nakai, T., and Miyabo, S. (1992) Biochem. Biophys. Res. Commun. 188, 934-941[CrossRef][Medline] [Order article via Infotrieve]
16. Chik, C. L., Li, B., Ogiwara, T., Ho, A. K., and Karpinski, E. (1996) FASEB J. 10, 1310-1317[Abstract]
17. Zhang, S., Hirano, Y., and Hiraoka, M. (1995) Circ. Res. 76, 592-599[Abstract/Free Full Text]
18. Lacerda, A. E., Rampe, D., and Brown, A. M. (1988) Nature 335, 249-251[CrossRef][Medline] [Order article via Infotrieve]
19. Tseng, G. N., and Boyden, P. A. (1991) Am. J. Physiol. 261, H364-H379[Abstract/Free Full Text]
20. Asai, T., Shuba, L. M., Pelzer, D. J., and McDonald, T. F. (1996) Am. J. Physiol. 270, H620-H627[Abstract/Free Full Text]
21. Bourinet, E., Fournier, F., Lory, P., Charnet, P., and Nargeot, J. (1992) Pfluegers Arch. 421, 247-255[CrossRef][Medline] [Order article via Infotrieve]
22. Singer-Lahat, D., Gershon, E., Lotan, I., Hullin, R., Biel, M., Flockerzi, V., Hofmann, F., and Dascal, N. (1992) FEBS Lett. 306, 113-118[CrossRef][Medline] [Order article via Infotrieve]
23. Yang, J., and Tsien, R. W. (1993) Neuron 10, 127-136[CrossRef][Medline] [Order article via Infotrieve]
24. Kleppisch, T., Klinz, F. J., and Hescheler, J. (1992) Brain Res. 591, 283-288[CrossRef][Medline] [Order article via Infotrieve]
25. Herman, M. D., Reuveny, E., and Narahashi, T. (1993) J. Physiol. (Lond). 462, 645-660[Abstract/Free Full Text]
26. Hall, K. E., Browning, M. D., Dudek, E. M., and Macdonald, R. L. (1995) J. Neurosci. 15, 6069-6076[Abstract]
27. Hsu, K. S., Huang, C. C., Kan, W. M., and Gean, P. W. (1996) Am. J. Physiol. 271, C1269-C1277[Abstract/Free Full Text]
28. ffrench-Mullen, J. M. (1995) J. Neurosci. 15, 903-911[Abstract]
29. Doerner, D., Pitler, T. A., and Alger, B. E. (1988) J. Neurosci. 8, 4069-4078[Abstract]
30. Catterall, W. A. (1993) Trends Neurosci. 16, 500-506[CrossRef][Medline] [Order article via Infotrieve]
31. Wei, X., Neely, A., Olcese, R., Lang, W., Stefani, E., and Birnbaumer, L. (1996) Recept. Channels 4, 205-215[Medline] [Order article via Infotrieve]
32. Schultz, D., Mikala, G., Yatani, A., Engle, D. B., Iles, D. E., Segers, B., Sinke, R. J., Weghuis, D. O., Klockner, U., Wakamori, M., Wang, J. J., Melvin, D., Varadi, G., and Schwartz, A. (1993) Proc. Natl. Acad. Sci. U. S. A. 90, 6228-6232[Abstract/Free Full Text]
33. Bouron, A., Soldatov, N. M., and Reuter, H. (1995) FEBS Lett. 377, 159-162[CrossRef][Medline] [Order article via Infotrieve]
34. Biel, M., Ruth, P., Bosse, E., Hullin, R., Stuhmer, W., Flockerzi, V., and Hofmann, F. (1990) FEBS Lett. 269, 409-412[CrossRef][Medline] [Order article via Infotrieve]
35. Yang, Y., Chen, X., and Houser, S. P. (1999) Biophys. J. 76, A431
36. Mikami, A., Imoto, K., Tanabe, T., Niidome, T., Mori, Y., Takeshima, H., Narumiya, S., and Numa, S. (1989) Nature 340, 230-233[CrossRef][Medline] [Order article via Infotrieve]
37. Shistik, E., Ivanina, T., Puri, T., Hosey, M., and Dascal, N. (1995) J. Physiol. (Lond.) 489, 55-62[Abstract/Free Full Text]
38. Chien, A. J., Zhao, X., Shirokov, R. E., Puri, T. S., Chang, C. F., Sun, D., Rios, E., and Hosey, M. M. (1995) J. Biol. Chem. 270, 30036-30044[Abstract/Free Full Text]
39. Kozasa, T., and Gilman, A. G. (1996) J. Biol. Chem. 271, 12562-12567[Abstract/Free Full Text]
40. Takagi, T. (1991) Adv. Electrophoresis 4, 391-406
41. Khan, I., Ahmad, S., and Thomas, N. (1998) Biochem. Mol. Biol. Int. 45, 895-904[Medline] [Order article via Infotrieve]
42. Gao, T., Puri, T. S., Gerhardstein, B. L., Chien, A. J., Green, R. D., and Hosey, M. M. (1997) J. Biol. Chem. 272, 19401-19407[Abstract/Free Full Text]
43. Yoshida, A., Takahashi, M., Nishimura, S., Takeshima, H., and Kokubun, S. (1992) FEBS Lett. 309, 343-349[CrossRef][Medline] [Order article via Infotrieve]
44. Brereton, H. M., Harland, M. L., Froscio, M., Petronijevic, T., and Barritt, G. J. (1997) Cell Calcium 22, 39-52[CrossRef][Medline] [Order article via Infotrieve]
45. Wei, X., Pan, S., Lang, W., Kim, H., Schneider, T., Perez Reyes, E., and Birnbaumer, L. (1995) J. Biol. Chem. 270, 27106-27111[Abstract/Free Full Text]


Copyright © 1999 by The American Society for Biochemistry and Molecular Biology, Inc.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Physiol. Rev.Home page
S. Dai, D. D. Hall, and J. W. Hell
Supramolecular Assemblies and Localized Regulation of Voltage-Gated Ion Channels
Physiol Rev, April 1, 2009; 89(2): 411 - 452.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
P. J. Leary, S. Rajasekaran, R. R. Morrison, E. I. Tuomanen, T. K. Chin, and P. A. Hofmann
A cardioprotective role for platelet-activating factor through NOS-dependent S-nitrosylation
Am J Physiol Heart Circ Physiol, June 1, 2008; 294(6): H2775 - H2784.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
H. E. D. J. ter Keurs and P. A. Boyden
Calcium and Arrhythmogenesis
Physiol Rev, April 1, 2007; 87(2): 457 - 506.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
G. Baroudi, Y. Qu, O. Ramadan, M. Chahine, and M. Boutjdir
Protein kinase C activation inhibits Cav1.3 calcium channel at NH2-terminal serine 81 phosphorylation site.
Am J Physiol Heart Circ Physiol, October 1, 2006; 291(4): H1614 - H1622.
[Abstract] [Full Text] [PDF]


Home page
JGPHome page
N. Kanevsky and N. Dascal
Regulation of Maximal Open Probability Is a Separable Function of Cav{beta} Subunit in L-type Ca2+ Channel, Dependent on NH2 Terminus of {alpha}1C (Cav1.2{alpha})
J. Gen. Physiol., June 26, 2006; 128(1): 15 - 36.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
P. Gui, X. Wu, S. Ling, S. C. Stotz, R. J. Winkfein, E. Wilson, G. E. Davis, A. P. Braun, G. W. Zamponi, and M. J. Davis
Integrin Receptor Activation Triggers Converging Regulation of Cav1.2 Calcium Channels by c-Src and Protein Kinase A Pathways
J. Biol. Chem., May 19, 2006; 281(20): 14015 - 14025.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
P. Liao, T. F. Yong, M. C. Liang, D. T. Yue, and T. W. Soong
Splicing for alternative structures of Cav1.2 Ca2+ channels in cardiac and smooth muscles
Cardiovasc Res, November 1, 2005; 68(2): 197 - 203.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
L. Yang, G. Liu, S. I. Zakharov, J. P. Morrow, V. O. Rybin, S. F. Steinberg, and S. O. Marx
Ser1928 Is a Common Site for Cav1.2 Phosphorylation by Protein Kinase C Isoforms
J. Biol. Chem., January 7, 2005; 280(1): 207 - 214.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
M. A.G. van der Heyden, T. J.M. Wijnhoven, and T. Opthof
Molecular aspects of adrenergic modulation of cardiac L-type Ca2+ channels
Cardiovasc Res, January 1, 2005; 65(1): 28 - 39.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
P. Liao, D. Yu, S. Lu, Z. Tang, M. C. Liang, S. Zeng, W. Lin, and T. W. Soong
Smooth Muscle-selective Alternatively Spliced Exon Generates Functional Variation in Cav1.2 Calcium Channels
J. Biol. Chem., November 26, 2004; 279(48): 50329 - 50335.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Z. Z. Tang, M. C. Liang, S. Lu, D. Yu, C. Y. Yu, D. T. Yue, and T. W. Soong
Transcript Scanning Reveals Novel and Extensive Splice Variations in Human L-type Voltage-gated Calcium Channel, Cav1.2 {alpha}1 Subunit
J. Biol. Chem., October 22, 2004; 279(43): 44335 - 44343.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
D. H. Korzick, M. H. Laughlin, and D. K. Bowles
Alterations in PKC signaling underlie enhanced myogenic tone in exercise-trained porcine coronary resistance arteries
J Appl Physiol, April 1, 2004; 96(4): 1425 - 1432.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. Weiss, T. Doan, K. E. Bernstein, and N. Dascal
Modulation of Cardiac Ca2+ Channel by Gq-activating Neurotransmitters Reconstituted in Xenopus Oocytes
J. Biol. Chem., March 26, 2004; 279(13): 12503 - 12510.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
G. L. Kamatchi, R. Franke, C. Lynch III, and J. J. Sando
Identification of Sites Responsible for Potentiation of Type 2.3 Calcium Currents by Acetyl-{beta}-methylcholine
J. Biol. Chem., February 6, 2004; 279(6): 4102 - 4109.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
C. E. Young and C. R. Yang
Dopamine D1/D5 Receptor Modulates State-Dependent Switching of Soma-Dendritic Ca2+ Potentials via Differential Protein Kinase A and C Activation in Rat Prefrontal Cortical Neurons
J. Neurosci., January 7, 2004; 24(1): 8 - 23.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
L. Protas, A. Barbuti, J. Qu, V. O. Rybin, R. D. Palmiter, S. F. Steinberg, and R. B. Robinson
Neuropeptide Y Is an Essential In Vivo Developmental Regulator of Cardiac ICa,L
Circ. Res., November 14, 2003; 93(10): 972 - 979.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Z. Lin, P.-W. Zhang, X. Zhu, J.-M. Melgari, R. Huff, R. L. Spieldoch, and G. R. Uhl
Phosphatidylinositol 3-Kinase, Protein Kinase C, and MEK1/2 Kinase Regulation of Dopamine Transporters (DAT) Require N-terminal DAT Phosphoacceptor Sites
J. Biol. Chem., May 23, 2003; 278(22): 20162 - 20170.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
K. B Walsh and G. E Parks
Changes in cardiac myocyte morphology alter the properties of voltage-gated ion channels
Cardiovasc Res, July 1, 2002; 55(1): 64 - 75.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Y. Blumenstein, N. Kanevsky, G. Sahar, R. Barzilai, T. Ivanina, and N. Dascal
A Novel Long N-terminal Isoform of Human L-type Ca2+ Channel Is Up-regulated by Protein Kinase C
J. Biol. Chem., January 25, 2002; 277(5): 3419 - 3423.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
K. D. Keef, J. R. Hume, and J. Zhong
Regulation of cardiac and smooth muscle Ca2+ channels (CaV1.2a,b) by protein kinases
Am J Physiol Cell Physiol, December 1, 2001; 281(6): C1743 - C1756.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
M. J. Davis, X. Wu, T. R. Nurkiewicz, J. Kawasaki, P. Gui, M. A. Hill, and E. Wilson
Regulation of ion channels by protein tyrosine phosphorylation
Am J Physiol Heart Circ Physiol, November 1, 2001; 281(5): H1835 - H1862.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
D. McHugh, E. M. Sharp, T. Scheuer, and W. A. Catterall
Inhibition of cardiac L-type calcium channels by protein kinase C phosphorylation of two sites in the N-terminal domain
PNAS, October 12, 2000; (2000) 210384297.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
T. Ivanina, Y. Blumenstein, E. Shistik, R. Barzilai, and N. Dascal
Modulation of L-type Ca2+ Channels by Gbeta gamma and Calmodulin via Interactions with N and C Termini of alpha 1C
J. Biol. Chem., December 15, 2000; 275(51): 39846 - 39854.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
D. McHugh, E. M. Sharp, T. Scheuer, and W. A. Catterall
Inhibition of cardiac L-type calcium channels by protein kinase C phosphorylation of two sites in the N-terminal domain
PNAS, October 24, 2000; 97(22): 12334 - 12338.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
K. J. Alden, P. H. Goldspink, S. W. Ruch, P. M. Buttrick, and J. Garcia
Enhancement of L-type Ca2+ current from neonatal mouse ventricular myocytes by constitutively active PKC-beta II
Am J Physiol Cell Physiol, April 1, 2002; 282(4): C768 - C774.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Shistik, E.
Right arrow Articles by Ivanina, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Shistik, E.
Right arrow Articles by Ivanina, T.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 1999 by the American Society for Biochemistry and Molecular Biology.
Advertisement
spacer
Advertisement
Advertisement